SCHEDULE: VivoSim Labs: Esousa Group, Wachs Own 9.9% Stake

Esousa Group Holdings LLC and Michael Wachs have disclosed a beneficial ownership of 9.9% in VivoSim Labs, Inc. common stock, totaling 319,429 shares, as of June 30, 2026.

Summary

• Esousa Group Holdings LLC and Michael Wachs have filed a Schedule 13G, indicating their beneficial ownership of 319,429 shares of VivoSim Labs, Inc. common stock.
• This ownership stake represents 9.9% of the class of securities outstanding as of June 30, 2026.
• The filing also notes that 576,542 additional shares are issuable upon exercise of common warrants.
• However, due to a Beneficial Ownership Limitation, the reporting persons cannot exercise these warrants if it would result in owning more than 9.9% of the outstanding common stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to the disclosure of a significant ownership stake but with limitations on exercising further rights due to beneficial ownership restrictions.

Positives

• Significant ownership stake disclosed by Esousa Group Holdings LLC and Michael Wachs, indicating investor interest.
• The reporting persons have sole voting and dispositive power over the 319,429 shares they beneficially own.

Negatives

• The Beneficial Ownership Limitation restricts the ability to exercise warrants, capping ownership at 9.9% and preventing the acquisition of additional shares through warrant exercise.
• The inability to exercise warrants means a substantial number of shares (576,542) remain inaccessible for ownership increase.

Risks

• The Beneficial Ownership Limitation may hinder the reporting persons' ability to increase their influence or stake in VivoSim Labs, Inc. beyond the 9.9% threshold.
• Future stock issuances or warrant exercises by others could dilute the reporting persons' 9.9% stake, potentially impacting their relative influence.

Future Outlook

The filing does not contain forward-looking statements or guidance. It primarily reports on current ownership status and limitations.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant shareholders to report their holdings. The specific mention of a Beneficial Ownership Limitation tied to warrants is a key detail that can impact a company's shareholder structure and potential for hostile takeovers or significant influence by a single entity.

Stakeholder Impact

• Shareholders: The 9.9% ownership by Esousa Group Holdings LLC and Michael Wachs, coupled with the inability to increase this stake via warrants due to limitations, could influence voting dynamics and strategic decisions.
• Management: The filing may signal a significant stakeholder whose influence is capped, potentially affecting future strategic discussions or board representation considerations.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, Warrants, Ownership Limitation, Esousa Group Holdings LLC, Michael Wachs, VivoSim Labs